VIEWPOINTS PharmaShots Interview: SalioGen Therapeutics’ Ray Tabibiazar Shares Insights on Gene Coding PlatformBySenior EditorMarch 8, 20220Comments
THOUGHTSPOT After Effects of Russia – Ukraine Conflict Over Pharma and Life Sciences IndustryBySenior EditorMarch 2, 20220Comments
VIEWPOINTS PharmaShots Interview: Clario’s Joyce Suhy Shares Insights on PET Imaging Clinical TrialsBySenior EditorMarch 1, 20220Comments
VIEWPOINTS PharmaShots Interview: Zai Lab’s Jonathan Wang Shares Insights on KarXT (xanomeline-trospium) for the Treatment of Schizophrenia And PsychosisBySenior EditorFebruary 28, 20220Comments
VIEWPOINTS PharmaShots Interview: Boston Scientific’s Ron Morton Shares Insights on the Rezūm Water Vapor TherapyBySenior EditorFebruary 24, 20220Comments
VIEWPOINTS PharmaShots Interview: GSK’s Tania Small Shares Insight on Target the Future ProgramBySenior EditorFebruary 23, 20220Comments
VIEWPOINTS PharmaShots Interview: Novartis’ Todd Fox Shares Insight on the US FDA’s Approval of Cosentyx for Enthesitis-Related Arthritis and Psoriatic ArthritisBySenior EditorFebruary 22, 20220Comments
